Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

J&J’s Imaavy Posts Win in Phase II SLE Trial

Summary by Clinical Trials Arena
J&J's Imaavy will now progress to Phase III in SLE, though it will face strong competition from SLE market leader, Benlysta if it reaches the market.The post J&J’s Imaavy posts win in Phase II SLE trial appeared first on Clinical Trials Arena.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

2 Articles

Clinical Trials ArenaClinical Trials Arena

J&J’s Imaavy posts win in Phase II SLE trial

J&J's Imaavy will now progress to Phase III in SLE, though it will face strong competition from SLE market leader, Benlysta if it reaches the market.The post J&J’s Imaavy posts win in Phase II SLE trial appeared first on Clinical Trials Arena.

Read Full Article
endpoints.newsendpoints.news

J&J plans late-stage trial for lupus candidate after Phase 2 success

Johnson & Johnson’s monoclonal antibody Imaavy succeeded in a mid-stage lupus trial, bringing the company one step closer to its goal of expanding the drug in other autoimmune diseases. Imaavy met its primary endpoint of ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Tuesday, January 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Pharma icon

Pharma

Johnson & Johnson icon

Johnson & Johnson

Health & Medicine icon

Health & Medicine

Business & Markets icon

Business & Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal